VRCA
Verrica Pharmaceuticals Inc
NASDAQ: VRCA · HEALTHCARE · BIOTECHNOLOGY
$6.37
-3.19% today
Updated 2026-04-30
Market cap
$112.18M
P/E ratio
—
P/S ratio
3.15x
EPS (TTM)
$-1.68
Dividend yield
—
52W range
$3 – $10
Volume
0.1M
Verrica Pharmaceuticals Inc (VRCA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-1.61M | $-4.58M | $-17.87M | $-27.41M | $-30.21M | $-27.58M | $-18.65M | $-38.58M | $-60.93M | $-17.63M |
| Capital expenditures | $774000.00 | $774000.00 | $774000.00 | $682000.00 | $1.47M | $883000.00 | $302000.00 | $362000.00 | $27000.00 | $0.00 |
| Depreciation | $20000.00 | $20000.00 | $20000.00 | $257199.00 | $229000.00 | $472000.00 | $718000.00 | $836000.00 | $1.27M | — |
| Stock-based comp | $9000.00 | $82000.00 | $2.25M | $3.33M | $9.82M | $6.05M | $4.99M | $14.38M | $7.16M | $3.32M |
| Free cash flow | $-2.38M | $-5.36M | $-18.65M | $-28.09M | $-31.68M | $-28.46M | $-18.95M | $-38.94M | $-60.95M | $-17.63M |
| Investing cash flow | $-79.89M | $-79.89M | $-79.89M | $25.95M | $-3.58M | $-998000.00 | $54.04M | $-362000.00 | $-19000.00 | — |
| Financing cash flow | $483000.00 | $12.72M | $99.38M | $423000.00 | $35.23M | $33.65M | $-16.87M | $74.21M | $37.73M | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $1.61M | $-1.03M | $1.45M | $5.07M | $18.52M | — | — | — |